Assays for hepatitis B surface antigen (HBsAg) are the most frequently used tests to detect HBV infection. Vaccination for HBV can produce transiently detectable levels of HBsAg in patients.

including hepatitis B e antigen (HBeAg) and hepatitis B s antigen (HBsAg), which is HBV’s envelope protein. In addition to the excess HBsAg present in circulating virions, large amounts of ...

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

Additionally, the hepatitis D virus (HDV), an enveloped RNA ... insight into how BLV interacts with NTCP, they generated an antigen-binding antibody fragment (Fab) specific to the NTCP-BLV complex.

These problems can be best addressed by systematic studies of antigen three-dimensional structure and further ... the production of a recombinant hepatitis B virus (HBV) vaccine 3.

Discover a clinical trial that was conducted to evaluate the efficacy and safety of autologous HBV vaccine-pulsed dendritic cells and their induced T cells.

New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.

In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients ...

Thirty-four HBsAg tests were performed on 34 different patients within 14 days of a dose of Engerix-B® hepatitis B vaccine, with 24 of these occurrences involving patients with chronic renal ...